A broader set of HLA genes were implicated in MS risk, as well genes not identified for AD including ABC transporter-related genes (TAP1, TAP2, TAPBPL) and MHC Class I and Class II-associated genes (MICB, CIITA). This evidence concerns the gene TAPBPL and myeloid sarcoma.